- Home
- STKS vs XGN Comparison
STKS vs XGN Comparison
Compare STKS & XGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | STKS | XGN |
|---|---|---|
| Founded | 2004 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.3M | 71.2M |
| IPO Year | 2011 | 2014 |
Fundamental Metrics
Financial Performance| Metric | STKS | XGN |
|---|---|---|
| Price | $1.89 | $3.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 7 |
| Target Price | $4.70 | ★ $8.86 |
| AVG Volume (30 Days) | 34.1K | ★ 409.0K |
| Earning Date | 05-04-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $805,722,000.00 | N/A |
| Revenue This Year | $7.47 | $8.12 |
| Revenue Next Year | $8.12 | $13.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 19.66 | N/A |
| 52 Week Low | $1.65 | $2.59 |
| 52 Week High | $5.19 | $12.23 |
Technical Indicators
Market Signals| Indicator | STKS | XGN |
|---|---|---|
| Relative Strength Index (RSI) | 53.25 | 59.73 |
| Support Level | $1.89 | $2.68 |
| Resistance Level | $2.03 | $3.89 |
| Average True Range (ATR) | 0.10 | 0.31 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 49.20 | 67.57 |
Price Performance
Historical ComparisonAbout STKS The ONE Group Hospitality Inc.
The One Group Hospitality Inc is a restaurant company that develops, owns and operates, manages and licenses upscale and polished casual, high-energy restaurants and lounges and provides turn-key food and beverage (F&B) services for hospitality venues, including hotels, casinos, and other high-end locations internationally. The company operates through three segments: STK, Benihana and Grill Concepts. The company generates the vast majority of its revenue from the domestic market.
About XGN Exagen Inc.
Exagen Inc is a medical technology company focused on the design, development and commercialization of diagnostic testing products under its AVISE brand. These products are used for the differential diagnosis, prognosis, and monitoring of rheumatic, autoimmune, and related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). The company operates in one operating segment. The majority of the company's revenue is derived from sales of its testing products.